Bionano Genomics, Inc. (BNGO) vs Lipocine Inc. (LPCN)

A side-by-side comparison of Bionano Genomics, Inc. and Lipocine Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BNGO vs LPCN

growth of $100 · dividends reinvested · last 8y
BNGO -100.0% (-62.5%/yr)LPCN -91.3% (-26.3%/yr)LPCN compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $1002020202220242026$0$9
BNGO LPCN

BNGO vs LPCN: by the numbers

  • •LPCN is the larger company ($17M vs $17M market cap).
  • •Both run net losses; BNGO's is the smaller (-106.58% vs -755.13% net margin).

Metrics side by side

Valuation

MetricBNGOLPCN
P/S ratio0.5610.90
P/B ratio0.530.79

Profitability

MetricBNGOLPCN
Gross margin21.95%-334.26%
Operating margin-116.95%-524.69%
Net margin-106.58%-755.13%
ROE-101.76%-54.45%
ROIC-85.72%-57.74%

Growth (annualized)

MetricBNGOLPCN
Revenue CAGR (5Y)17.97%N/A
Total return CAGR (5Y)-78.37%-34.76%

Frequently asked

How have BNGO and LPCN total returns compared?
Over the past 5 years, BNGO delivered -78.37% and LPCN delivered -34.76% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.